Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $62 at SVB Leerink

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $62 at SVB Leerink

Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $55 at Morgan Stanley

July 15, 2019 8:46 AM EDT

Morgan Stanley analyst Matthew Harrison lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $55.00 (from $57.00) while maintaining a Equalweight rating.

... More

Biohaven (BHVN) Reports Publication of Positive Phase 3 Trial of Rimegepant Zydis

July 15, 2019 7:32 AM EDT

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announces that The Lancet published online positive results from a Phase 3 pivotal clinical trial of rimegepant Zydis® orally dissolving tablet (ODT) for the acute treatment of migraine. These data show that compared to placebo, patients treated with a single dose of the rimegepant ODT formulation experienced rapid and sustained clinical benefits.

"The results from this pivotal Phase 3 study show the... More